Kyongbo Pharmaceutical Co., Ltd (214390.KS) KSC
6,320.00
-30(-0.47%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 137.75B |
| Enterprise Value | 257.19B |
| P/E Ratio | 583.9 |
| PEG Ratio | -6.56 |
| Price/Sales Ratio | 0.56 |
| Price/Book Ratio | 1.05 |
| Enterprise/Revenue | 1.01 |
| Enterprise/EBITDA | 19.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0.02 |
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 264.1B |
| Revenue/Share | 11,278.82 |
| Gross Profit | 99.97B |
| EBITDA | 16.72B |
| Net Income | 108.05M |
| Diluted EPS | 4.52 |
Balance Sheet
| Total Cash | 8.05B |
| Total Cash/Share | 336.66 |
| Total Debt | 126.67B |
| Total Debt/Equity | 0.87 |
| Current Ratio | 1.08 |
| Book Value Per Share | 6,083.52 |
Price History
| 52-Week Change | 17.96 |
| 52-Week High | 9,300 |
| 52-Week Low | 4,755 |
| Moving Average 50 Days | 6,752.6 |
| Moving Average 200 Days | 6,005.15 |
Statistics
| Average Volume | 1.14M |
| Shares Outstanding | 23.91M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 0.78 |
| Payout Ratio | 4.58 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
